Skip to main content
Erschienen in: Obesity Surgery 5/2024

19.03.2024 | Original Contributions

Early Marginal Ulcer After Roux-en-Y Gastric Bypass: MBSAQIP Database Analysis of Trends and Predictive Factors

verfasst von: Jorge Cornejo, Lorna A. Evans, Nafiye Busra Celik, Enrique F. Elli

Erschienen in: Obesity Surgery | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Marginal ulcer (MU) is a known complication after Roux-en-Y gastric bypass (RYGB) that carries significant morbidity. First, we aimed to determine the trends and the rates of readmission, reintervention, and reoperation of 30-day MU. Second, we aim to determine the predictive factors associated with this complication.

Materials and Methods

Patients who had 30-day marginal ulcer (MU) after LRYGB were identified using the 2015–2021 MBSAQIP database. Those who had a 30-day complication other than MU were excluded. Bivariate and logistic regression analyses were performed.

Results

Among 213,104 patients undergoing laparoscopic RYGB, 638 (0.3%) showed 30-day MU. This group of patients required endoscopic interventions, readmissions, and reoperations at rates of 88%, 72%, and 9%, respectively. Predictive factors for 30-day MU after RYGB were renal insufficiency, history of DVT, previous cardiac stent, African American race, chronic steroid use, COPD, therapeutic anticoagulation, anastomotic leak test, GERD, and operative time > 120 min. Additionally, patients who had 30-day MU showed significantly higher rates of overall complications such as pulmonary, cardiac and renal complications, unplanned ICU admission, blood transfusions, venous thromboembolism (VTE), and non-home discharge (p < 0.05). The MU group showed similar rates of 30-day mortality as those without this complication (0.2% vs 0.1%, p = 0.587).

Conclusions

The incidence of 30-day MU following RYGB was 0.3%. Patients with MU required endoscopic interventions, readmissions, and reoperations at rates of 88%, 72%, and 9%, respectively. Some preoperative and intraoperative factors contributed to an increased risk of 30-day MU.

Graphical Abstract

Literatur
2.
Zurück zum Zitat Carr WR, Mahawar KK, Balupuri S, et al. An evidence-based algorithm for the management of marginal ulcers following Roux-en-Y gastric bypass. Obes Surg. 2014;24(9):1520–7.CrossRefPubMed Carr WR, Mahawar KK, Balupuri S, et al. An evidence-based algorithm for the management of marginal ulcers following Roux-en-Y gastric bypass. Obes Surg. 2014;24(9):1520–7.CrossRefPubMed
3.
Zurück zum Zitat Beran A, Shaear M, Al-Mudares S, et al. Predictors of marginal ulcer after gastric bypass: a systematic review and meta-analysis. J Gastrointest Surg. 2023;27(6):1066–77.CrossRefPubMed Beran A, Shaear M, Al-Mudares S, et al. Predictors of marginal ulcer after gastric bypass: a systematic review and meta-analysis. J Gastrointest Surg. 2023;27(6):1066–77.CrossRefPubMed
5.
Zurück zum Zitat El-Hayek K, Timratana P, Shimizu H, et al. Marginal ulcer after Roux-en-Y gastric bypass: what have we really learned? Surg Endosc. 2012;26(10):2789–96.CrossRefPubMed El-Hayek K, Timratana P, Shimizu H, et al. Marginal ulcer after Roux-en-Y gastric bypass: what have we really learned? Surg Endosc. 2012;26(10):2789–96.CrossRefPubMed
6.
Zurück zum Zitat Lee JK, Van Dam J, Morton JM, et al. Endoscopy is accurate, safe, and effective in the assessment and management of complications following gastric bypass surgery. Am J Gastroenterol. 2009;104(3):575–82.PubMed Lee JK, Van Dam J, Morton JM, et al. Endoscopy is accurate, safe, and effective in the assessment and management of complications following gastric bypass surgery. Am J Gastroenterol. 2009;104(3):575–82.PubMed
7.
Zurück zum Zitat Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24(2):299–309.CrossRefPubMed Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24(2):299–309.CrossRefPubMed
8.
Zurück zum Zitat Verhoeff K, Mocanu V, Dang J, et al. Effect of the COVID-19 pandemic on bariatric surgery in North America: a retrospective analysis of 834,647 patients. Surg Obes Relat Dis. 2022;18(6):803–11.CrossRefPubMedPubMedCentral Verhoeff K, Mocanu V, Dang J, et al. Effect of the COVID-19 pandemic on bariatric surgery in North America: a retrospective analysis of 834,647 patients. Surg Obes Relat Dis. 2022;18(6):803–11.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Carter J, Chang J, Birriel TJ, et al. ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery. Surg Obes Relat Dis. 2021;17(12):1956–76.CrossRefPubMed Carter J, Chang J, Birriel TJ, et al. ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery. Surg Obes Relat Dis. 2021;17(12):1956–76.CrossRefPubMed
10.
Zurück zum Zitat Giannopoulos S, Athanasiadis DI, Clapp B, et al. Proton pump inhibitor prophylaxis after Roux-en-Y gastric bypass: a national survey of surgeon practices. Surg Obes Relat Dis. 2023;19(4):303–8.CrossRefPubMed Giannopoulos S, Athanasiadis DI, Clapp B, et al. Proton pump inhibitor prophylaxis after Roux-en-Y gastric bypass: a national survey of surgeon practices. Surg Obes Relat Dis. 2023;19(4):303–8.CrossRefPubMed
11.
Zurück zum Zitat Csendes A, Burgos AM, Altuve J, et al. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg. 2009;19(2):135–8.CrossRefPubMed Csendes A, Burgos AM, Altuve J, et al. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg. 2009;19(2):135–8.CrossRefPubMed
12.
Zurück zum Zitat Pantea M, Negovan A, Banescu C, et al. Factors associated with recurrent ulcers in patients with gastric surgery after more than 15 years: a cross-sectional single-center study. Gastroenterol Res Pract. 2018;2018:8319481.CrossRefPubMedPubMedCentral Pantea M, Negovan A, Banescu C, et al. Factors associated with recurrent ulcers in patients with gastric surgery after more than 15 years: a cross-sectional single-center study. Gastroenterol Res Pract. 2018;2018:8319481.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Cheung J, Yu A, LaBossiere J, et al. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease. Gastrointest Endosc. 2010;71(1):44–9.CrossRefPubMed Cheung J, Yu A, LaBossiere J, et al. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease. Gastrointest Endosc. 2010;71(1):44–9.CrossRefPubMed
14.
Zurück zum Zitat Rodrigo DC, Jill S, Daniel M, et al. Which factors correlate with marginal ulcer after surgery for obesity? Obes Surg. 2020;30(12):4821–7.CrossRefPubMed Rodrigo DC, Jill S, Daniel M, et al. Which factors correlate with marginal ulcer after surgery for obesity? Obes Surg. 2020;30(12):4821–7.CrossRefPubMed
15.
Zurück zum Zitat Sverdén E, Mattsson F, Sondén A, et al. Risk factors for marginal ulcer after gastric bypass surgery for obesity: a population-based cohort study. Ann Surg. 2016;263(4):733–7.CrossRefPubMed Sverdén E, Mattsson F, Sondén A, et al. Risk factors for marginal ulcer after gastric bypass surgery for obesity: a population-based cohort study. Ann Surg. 2016;263(4):733–7.CrossRefPubMed
16.
Zurück zum Zitat Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med. 1994;236(6):619–32.CrossRefPubMed Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med. 1994;236(6):619–32.CrossRefPubMed
17.
Zurück zum Zitat Coblijn UK, Lagarde SM, de Castro SM, et al. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes Surg. 2015;25(5):805–11.CrossRefPubMed Coblijn UK, Lagarde SM, de Castro SM, et al. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes Surg. 2015;25(5):805–11.CrossRefPubMed
18.
Zurück zum Zitat Clapp B, Hahn J, Dodoo C, et al. Evaluation of the rate of marginal ulcer formation after bariatric surgery using the MBSAQIP database. Surg Endosc. 2019;33(6):1890–7.CrossRefPubMed Clapp B, Hahn J, Dodoo C, et al. Evaluation of the rate of marginal ulcer formation after bariatric surgery using the MBSAQIP database. Surg Endosc. 2019;33(6):1890–7.CrossRefPubMed
19.
Zurück zum Zitat AbiMosleh K, Belluzzi A, Salame M, et al. Long-term outcomes of bariatric surgery in patients on chronic anticoagulation. Obes Surg. 2023;33(12):4007–16.CrossRef AbiMosleh K, Belluzzi A, Salame M, et al. Long-term outcomes of bariatric surgery in patients on chronic anticoagulation. Obes Surg. 2023;33(12):4007–16.CrossRef
20.
Zurück zum Zitat White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123(Suppl 4):S11–7.CrossRefPubMed White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123(Suppl 4):S11–7.CrossRefPubMed
22.
Zurück zum Zitat Mason EE, Munns JR, Kealey GP, et al. Effect of gastric bypass on gastric secretion. Am J Surg. 1976;131(2):162–8.CrossRefPubMed Mason EE, Munns JR, Kealey GP, et al. Effect of gastric bypass on gastric secretion. Am J Surg. 1976;131(2):162–8.CrossRefPubMed
23.
Zurück zum Zitat Gilmore MM, Kallies KJ, Mathiason MA, et al. Varying marginal ulcer rates in patients undergoing laparoscopic Roux-en-Y gastric bypass for morbid obesity versus gastroesophageal reflux disease: is the acid pocket to blame? Surg Obes Relat Dis. 2013;9(6):862–6.CrossRefPubMed Gilmore MM, Kallies KJ, Mathiason MA, et al. Varying marginal ulcer rates in patients undergoing laparoscopic Roux-en-Y gastric bypass for morbid obesity versus gastroesophageal reflux disease: is the acid pocket to blame? Surg Obes Relat Dis. 2013;9(6):862–6.CrossRefPubMed
24.
Zurück zum Zitat Jordan JH, Hocking MP, Rout WR, et al. Marginal ulcer following gastric bypass for morbid obesity. Am Surg. 1991;57(5):286–8.PubMed Jordan JH, Hocking MP, Rout WR, et al. Marginal ulcer following gastric bypass for morbid obesity. Am Surg. 1991;57(5):286–8.PubMed
25.
Zurück zum Zitat Fakas S, Elias M, Lim D, et al. Comparison of gastrojejunostomy techniques and anastomotic complications: a systematic literature review. Surg Endosc. 2021;35(12):6489–96.CrossRefPubMed Fakas S, Elias M, Lim D, et al. Comparison of gastrojejunostomy techniques and anastomotic complications: a systematic literature review. Surg Endosc. 2021;35(12):6489–96.CrossRefPubMed
27.
Zurück zum Zitat Hurwitz N, Segal M, Marbach I, et al. Differential activation of yeast adenylyl cyclase by Ras1 and Ras2 depends on the conserved N terminus. Proc Natl Acad Sci U S A. 1995;92(24):11009–13.CrossRefPubMedPubMedCentral Hurwitz N, Segal M, Marbach I, et al. Differential activation of yeast adenylyl cyclase by Ras1 and Ras2 depends on the conserved N terminus. Proc Natl Acad Sci U S A. 1995;92(24):11009–13.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc. 2007;21(7):1090–4.CrossRefPubMed Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc. 2007;21(7):1090–4.CrossRefPubMed
29.
Zurück zum Zitat Süsstrunk J, Wartmann L, Mattiello D, et al. Incidence and prognostic factors for the development of symptomatic and asymptomatic marginal ulcers after Roux-en-Y gastric bypass procedures. Obes Surg. 2021l;31(7):3005–14.CrossRefPubMed Süsstrunk J, Wartmann L, Mattiello D, et al. Incidence and prognostic factors for the development of symptomatic and asymptomatic marginal ulcers after Roux-en-Y gastric bypass procedures. Obes Surg. 2021l;31(7):3005–14.CrossRefPubMed
30.
Zurück zum Zitat Bjarnason I, Scarpignato C, Holmgren E, et al. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology. 2018;154(3):500–14.CrossRefPubMed Bjarnason I, Scarpignato C, Holmgren E, et al. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology. 2018;154(3):500–14.CrossRefPubMed
31.
Zurück zum Zitat Skogar ML, Sundbom M. Nonsteroid anti-inflammatory drugs and the risk of peptic ulcers after gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis. 2022;18(7):888–93.CrossRefPubMed Skogar ML, Sundbom M. Nonsteroid anti-inflammatory drugs and the risk of peptic ulcers after gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis. 2022;18(7):888–93.CrossRefPubMed
32.
Zurück zum Zitat Dittrich L, Schwenninger MV, Dittrich K, et al. Marginal ulcers after laparoscopic Roux-en-Y gastric bypass: analysis of the amount of daily and lifetime smoking on postoperative risk. Surg Obes Relat Dis. 2020;16(3):389–96.CrossRefPubMed Dittrich L, Schwenninger MV, Dittrich K, et al. Marginal ulcers after laparoscopic Roux-en-Y gastric bypass: analysis of the amount of daily and lifetime smoking on postoperative risk. Surg Obes Relat Dis. 2020;16(3):389–96.CrossRefPubMed
33.
Zurück zum Zitat Li LF, Chan RL, Lu L, et al. Cigarette smoking and gastrointestinal diseases: the causal relationship and underlying molecular mechanisms (review). Int J Mol Med. 2014;34(2):372–80.CrossRefPubMed Li LF, Chan RL, Lu L, et al. Cigarette smoking and gastrointestinal diseases: the causal relationship and underlying molecular mechanisms (review). Int J Mol Med. 2014;34(2):372–80.CrossRefPubMed
34.
Zurück zum Zitat Boerlage TCC, Wolvers PJD, Bruin SC, et al. Upper endoscopy after Roux-en-Y gastric bypass: diagnostic yield and factors associated with relevant findings. Surg Obes Relat Dis. 2020;16(7):868–76.CrossRefPubMed Boerlage TCC, Wolvers PJD, Bruin SC, et al. Upper endoscopy after Roux-en-Y gastric bypass: diagnostic yield and factors associated with relevant findings. Surg Obes Relat Dis. 2020;16(7):868–76.CrossRefPubMed
35.
Zurück zum Zitat Engen PA, Green SJ, Voigt RM, et al. The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota. Alcohol Res. 2015;37(2):223–36.PubMedPubMedCentral Engen PA, Green SJ, Voigt RM, et al. The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota. Alcohol Res. 2015;37(2):223–36.PubMedPubMedCentral
36.
Zurück zum Zitat Steinemann DC, Bueter M, Schiesser M, et al. Management of anastomotic ulcers after Roux-en-Y gastric bypass: results of an international survey. Obes Surg. 2014;24(5):741–6.CrossRefPubMed Steinemann DC, Bueter M, Schiesser M, et al. Management of anastomotic ulcers after Roux-en-Y gastric bypass: results of an international survey. Obes Surg. 2014;24(5):741–6.CrossRefPubMed
37.
Zurück zum Zitat Schulman AR, Chan WW, Devery A, et al. Opened proton pump inhibitor capsules reduce time to healing compared with intact capsules for marginal ulceration following Roux-en-Y gastric bypass. Clin Gastroenterol Hepatol. 2017;15(4):494-500.e1.CrossRefPubMed Schulman AR, Chan WW, Devery A, et al. Opened proton pump inhibitor capsules reduce time to healing compared with intact capsules for marginal ulceration following Roux-en-Y gastric bypass. Clin Gastroenterol Hepatol. 2017;15(4):494-500.e1.CrossRefPubMed
38.
Zurück zum Zitat Kumbhari V, le Roux CW, Cohen RV. Endoscopic evaluation and management of late complications after bariatric surgery: a narrative review. Obes Surg. 2021;31(10):4624–33.CrossRefPubMed Kumbhari V, le Roux CW, Cohen RV. Endoscopic evaluation and management of late complications after bariatric surgery: a narrative review. Obes Surg. 2021;31(10):4624–33.CrossRefPubMed
Metadaten
Titel
Early Marginal Ulcer After Roux-en-Y Gastric Bypass: MBSAQIP Database Analysis of Trends and Predictive Factors
verfasst von
Jorge Cornejo
Lorna A. Evans
Nafiye Busra Celik
Enrique F. Elli
Publikationsdatum
19.03.2024
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 5/2024
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-024-07179-4

Weitere Artikel der Ausgabe 5/2024

Obesity Surgery 5/2024 Zur Ausgabe

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.